Article
The importance of HCV RNA measurement for tailoring treatment duration.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 30 Sept 2013
Peiffer Kai-Henrik, Sarrazin Christoph
Abstract excerpt
The introduction of telaprevir and boceprevir in the treatment of chronically HCV genotype 1 infected patients has led to substantially improved sustained virologic response rates and shorter treatment duration for a growing group of patients. Management and monitoring of patients receiving protease inhibitor-based triple therapy is of major importance and has become more complicated. Close monitoring of HCV RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.